CSBIO(300255)

Search documents
龙虎榜 | 成都系、佛山系爆买短剧游戏股,北京光华路超2亿砸盘利民股份
Ge Long Hui· 2025-06-19 10:28
Market Overview - On June 19, A-shares opened lower and continued to decline, with the Shanghai Composite Index falling by 0.79% to 3362 points, the Shenzhen Component Index down by 1.21%, and the ChiNext Index down by 1.36%, with over 4600 stocks declining across the market [1] - Market focus shifted towards the oil, natural gas, and digital reading sectors [1] High-Performing Stocks - In the oil and gas sector, Zhuan Oil Co. and Shandong Molong achieved five consecutive trading limits, while military stock Beifang Changlong saw a 20% increase over three days [3] - Notable stocks with significant gains include: - Shandong Quanlong: +10.00%, five consecutive limits [4] - Zhuan Oil Co.: +9.96%, five consecutive limits [4] - Beifang Changlong: +20.01%, three limits in five days [4] - Innovation Medical: +10.04%, two limits in three days [4] Trading Activity - The top three net purchases on the Dragon and Tiger list were: - Innovation Medical: net purchase of 207 million [5] - Electric Science Cybersecurity: net purchase of 153 million [5] - Anni Co.: net purchase of 135 million [5] - The top three net sales were: - Limin Co.: net sale of 230 million [7] - Xiexin Energy: net sale of 218 million [7] - Changshan Pharmaceutical: net sale of 178 million [7] Sector Highlights - Innovation Medical focuses on brain-machine interfaces and AI medical models, achieving a trading limit with a turnover of 1.745 billion and a turnover rate of 31.78% [10] - Baida Qiancheng, involved in short drama games and major contract signings, also reached a trading limit with a turnover of 1.077 billion [14] - Electric Science Cybersecurity, which focuses on digital currency and satellite navigation, achieved a trading limit with a turnover of 694 million [18] Institutional Activity - Institutions showed significant interest in several stocks, with net purchases in: - Electric Science Cybersecurity: 35 million [22] - Innovation Medical: 26 million [22] - Shandong Molong: 20 million [22] - Conversely, institutions sold off stocks like Limin Co. and Xiexin Energy, with net sales of 64 million and 71 million respectively [19][22] Conclusion - The market experienced a downward trend with specific sectors like oil and gas showing resilience through notable stock performances. Institutional trading patterns indicate selective interest in high-growth potential stocks, particularly in the technology and healthcare sectors.
常山药业龙虎榜数据(6月19日)
Zheng Quan Shi Bao Wang· 2025-06-19 09:01
Group 1 - The stock of Changshan Pharmaceutical experienced a limit down, with a trading volume of 33.95 billion and a turnover rate of 7.18%, reflecting a price drop of 20.00% at the close [2] - Institutional investors net sold 97.06 million, while the Shenzhen Stock Connect recorded a net sell of 74.57 million [2] - The top five trading departments accounted for a total transaction of 699 million, with a net sell of 17.8 million [2][3] Group 2 - Over the past six months, the stock has appeared on the trading leaderboard five times, with an average price increase of 3.12% the day after being listed and an average increase of 6.28% over the following five days [3] - The stock saw a net outflow of 617 million in principal funds today, with large orders contributing to a net outflow of 565 million [3] - The trading data shows that the top buying and selling departments included the Shenzhen Stock Connect, which was both the largest buyer and seller, with buying and selling amounts of 95.96 million and 171 million respectively [3][4]
常山药业今日跌停 三机构专用席位净卖出9705.97万元
news flash· 2025-06-19 08:28
暗盘资金正涌入这些股票,点击速看>>> 常山药业(300255)今日跌停,成交额33.95亿元,换手率7.18%,盘后龙虎榜数据显示,深股通专用席 位买入9596.40万元并卖出1.71亿元,三机构专用席位净卖出9705.97万元。 ...
“高位股”震荡,A股调整
新华网财经· 2025-06-19 04:37
Market Overview - A-share market experienced a "high-low switch" with strong sectors like innovative drugs, controllable nuclear fusion, and digital currency facing adjustments, while previously weak humanoid robot sector rebounded significantly [1][2] - High-position stocks faced significant fluctuations, with companies like Changshan Pharmaceutical and Yong'an Pharmaceutical hitting the daily limit down, contributing to a 1.98% drop in the micro-cap stock index [2] Index Performance - As of the morning close, the Shanghai Composite Index fell by 0.86% to 3359.78, the Shenzhen Component Index decreased by 1.01% to 10072.42, and the ChiNext Index dropped by 1.1% to 2032.19 [3] Innovative Drug Sector - The innovative drug sector saw a pullback, with Changshan Pharmaceutical hitting a 20% daily limit down and other stocks like Hanyu Pharmaceutical also experiencing significant declines [5][6] - Despite the current adjustments, institutions remain optimistic about the innovative drug sector's investment opportunities in the second half of the year, citing supportive policies and improving fundamentals [8] Solid-State Battery Sector - The solid-state battery sector showed strong performance in the morning, with stocks like Haike Xinyuan and others experiencing significant gains [10] - Key factors driving the solid-state battery sector include policy support, breakthroughs in research by leading battery manufacturers, continuous optimization of equipment, and unexpected commercial progress [11][12][13]
【帮主郑重午评】创业板半日跌超1%!4600只股下跌背后藏着这些信号
Sou Hu Cai Jing· 2025-06-19 04:02
Market Overview - The three major indices experienced a decline, with the ChiNext Index dropping by 1.1% and over 4600 stocks in the market showing negative performance [1][3] - The Shanghai Composite Index fell by 0.86%, the Shenzhen Component Index decreased by 1.01%, and the North China 50 Index also saw a nearly 1% drop, with trading volume exceeding 800 billion, an increase of over 40 billion compared to the previous day [3] Economic Factors - Recent macroeconomic data has shown signs of pressure, leading to hesitance in market recovery expectations [3] - Popular sectors such as AI and weight-loss drugs are experiencing corrections, prompting funds to shift towards defensive sectors [3] - External market instability has also contributed to negative sentiment in the domestic market [3] Sector Performance - Solid-state batteries, PCB, and oil sectors saw gains, with stocks like Nord and Xiangtan Electric achieving limit-up [3] - The solid-state battery sector is gaining attention due to recent technological breakthroughs and a reasonable valuation after previous adjustments in the new energy sector [3] - The oil sector's rise may be linked to geopolitical tensions in the Middle East, particularly the potential for U.S. actions against Iran, leading to short-term oil price volatility [3] Declining Sectors - The nuclear fusion, military, and weight-loss drug sectors faced significant declines, with Changshan Pharmaceutical hitting the limit down and Hanyu Pharmaceutical dropping over 10% [4] - The military sector's adjustment is attributed to a lack of new catalysts, leading to fund withdrawals [4] - The nuclear power sector saw stocks like Hezhan Intelligent and China Nuclear Technology hitting the limit down, possibly due to negative news from specific companies [4] Investment Strategy - In a broad market decline, it is essential to maintain a calm mindset and focus on identifying quality stocks [4] - Long-term investors should prioritize company fundamentals and industry prospects over short-term price fluctuations [4] - The solid-state battery sector is highlighted as a promising long-term investment, while caution is advised in the weight-loss drug sector due to speculative trading [4]
创新药概念延续调整 常山药业触及跌停
news flash· 2025-06-19 01:54
智通财经6月19日电,早盘创新药概念延续调整,常山药业触及20CM跌停,翰宇药业跌超10%,通化金 马、广生堂、赛升药业、舒泰神等跟跌。 创新药概念延续调整 常山药业触及跌停 ...
化学制药板块短线走低 常山药业跌超12%
news flash· 2025-06-19 01:48
Group 1 - The chemical pharmaceutical sector has experienced a short-term decline, with Changshan Pharmaceutical (300255) dropping over 12% [1] - Other companies such as Yong'an Pharmaceutical (002365), Hanyu Pharmaceutical (300199), Tonghua Jinma (000766), and Guangshengtang (300436) also saw declines [1] - There is an influx of dark pool funds entering these stocks [1]
A股五张图:今晚要发生大事,不会是要15投了吧
Xuan Gu Bao· 2025-06-18 10:31
Market Overview - The market saw a slight overall increase, with the Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index rising by 0.04%, 0.24%, and 0.23% respectively, while nearly 3,500 stocks declined and about 1,800 stocks rose [4] Stablecoin - Stablecoin concepts are gaining traction, with JD Group's chairman expressing intentions to apply for stablecoin licenses globally to reduce cross-border payment costs by 90% and improve efficiency to under 10 seconds [7] - The People's Bank of China governor highlighted the role of blockchain and distributed ledger technology in enhancing the development of central bank digital currencies and stablecoins, indicating a growing global demand for improved cross-border payment systems [7][8] - Traditional cross-border payment systems are slow, taking 3-5 business days on average, while stablecoins can facilitate direct peer-to-peer settlements, potentially replacing traditional methods in the future [8] Methanol - Methanol stocks are performing well, with Jin Niu Chemical achieving a four-day consecutive increase, driven by strong demand from major production and export regions like Iran amidst geopolitical tensions [9][11] - The market dynamics show a divergence in performance, with some stocks like Jiang Tian Chemical experiencing significant declines while others thrive [14] Military Industry - The military sector is showing strength, with several stocks like Changcheng Military Industry and New Light Optoelectronics hitting their daily limits, driven by ongoing tensions in the Middle East [15][17] - The military sector index rose by 0.68%, reflecting a correlation with oil and gas sectors due to geopolitical factors [17] Innovative Pharmaceuticals - The innovative pharmaceutical sector is experiencing a pullback, with leading stocks like Shutai Shen facing declines, while Changshan Pharmaceutical saw a significant increase of nearly 15%, marking a 200% rise year-to-date [20] - The stock has shown a tenfold increase over two and a half years, indicating strong market interest in weight-loss drugs [20]
常山药业股价创新高,融资客抢先加仓
Zheng Quan Shi Bao Wang· 2025-06-18 01:57
证券时报·数据宝统计显示,常山药业所属的医药生物行业,目前整体跌幅为0.46%,行业内,目前股价 上涨的有80只,涨幅居前的有爱朋医疗、创新医疗、永安药业等,涨幅分别为11.58%、8.31%、 7.35%。股价下跌的有399只,跌幅居前的有广生堂、千红制药、力生制药等,跌幅分别为7.95%、 4.74%、4.39%。 两融数据显示,该股最新(6月17日)两融余额为14.03亿元,其中,融资余额为14.03亿元,近10日增加 4.15亿元,环比增长42.06%。 常山药业股价再创历史新高,该股近期呈不断突破新高之势,近一个月累计有10个交易日股价刷新历史 纪录。截至09:36,该股目前上涨3.20%,股价报54.48元,成交823.60万股,成交金额4.41亿元,换手率 0.90%,该股最新A股总市值达500.70亿元,该股A股流通市值499.08亿元。 公司6月11日在交易所互动平台披露,截至最新(6月10日)股东户数为50546户,较上期(5月31日)增 加7415户,环比增长17.19%。这是该股股东户数连续第2期增长,也就是说筹码呈持续分散趋势。 公司发布的一季报数据显示,一季度公司共实现营业收入2. ...